ArmelleSandrin-Deforge

Of Counsel

Paris + 33.1.56.59.39.47

Armelle Sandrin-Deforge's practice focuses on French, European, and international environmental law, including energy, health and safety, and regulatory issues. Her experience covers industrial facilities, contaminated sites, waste, renewable energy, climate change, marine and coastal environmental issues, asbestos, and Legionella. She advises on regulatory and litigation matters. Armelle has extensive experience in environmental issues related to M&A, particularly in environmental audits, environmental representation, and warranties. She also provides services to French and international clients with respect to environmental and sustainable development reporting in connection with capital markets transactions.

Armelle is particularly involved in the life science and pharmaceutical industries and is part of the Firm's multidisciplinary team that works to anticipate and respond to the new challenges facing this sector. She has represented major manufacturers, distributors, and users of medical devices, products, and services in transactional, regulatory, enforcement, and litigation matters in the life science area.

Armelle is the author of numerous publications on environmental and energy law. She teaches a renewable energy course at the University of Paris V-René Descartes and participates in environmental law and life science conferences. She is a member of the France Fulbright Alumni Association.

Experience

  • Framatome acquires Rolls-Royce Civil Nuclear Instrumentation and Control business in France and ChinaJones Day advised Framatome, an international leader in nuclear energy recognized for its innovative solutions and value added technologies for the global nuclear fleet, in its acquisition of the Rolls-Royce Civil Nuclear Instrumentation and Control business in France and China.
  • Forsee Power completes €115 million offering and IPO on regulated market of Euronext in ParisJones Day advised Forsee Power in connection with its initial public offering on the regulated market of Euronext in Paris and an offering of up to €115 million.
  • Waga Energy completes €110 million IPO on Euronext in Paris, with green shoe optionJones Day advised Waga Energy, a French company specialized in the recovery of landfill gas as biomethane, in connection with its €110 million initial public offering of Ordinary Shares on the regulated market of Euronext in Paris with an over-allotment option up to €123 million.
  • Framatome acquires ValinoxJones Day advised Framatome SAS in the acquisition of 100% of the shares of Valinox Nucléaire SAS, a French company specializing in the production of seamless tubes for nuclear use, from the Vallourec group.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Reno De Medici sells 100% interest in R.D.M. La Rochette S.A.S.Jones Day advised Reno De Medici SpA in the sale of its 100% interest in R.D.M. La Rochette S.A.S. to La Rochette Holding S.A.S., 100% owned by Mutares SE & Co. KgaA.
  • HealthHero acquires QareJones Day advised HealthHero in its acquisition of Qare, a French platform that provides medical video consultation services, backed by Kamet Ventures.
  • Solvay sold Process Materials business to Composites OneJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, in the sale of its Process Materials business, to Composites One, the leading North American supplier of composites materials and value added services.
  • DataBank acquires zColo for $1.4 billionJones Day advised DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, in connection with the acquisition and financing of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc. for $1.4 billion.
  • French Gas Association appeals for annulment of energy regulationsJones Day represents the French Gas Association (AFG) before the Conseil d’État, the French administrative supreme court, in petitioning for the annulment of various provisions that determine technical factors of energy sources as outlined in the Multiannual Energy Programme (PPE) that was adopted in a Decree dated April 21, 2020.
  • Milliken & Company acquires Borchers from The Jordan CompanyJones Day advised Milliken & Company in its acquisition of Borchers Group Limited, a global specialty chemicals company known for its innovative high-performance coating additives and specialty catalyst solutions, from The Jordan Company, L.P.
  • Total Quadran sold 50% stake in two holding companies holding wind and solar assets in France to la Caisse des Dépôts et ConsignationsJones Day advised Total Quadran in the sale by the Quadran group, which is part of the Total group, of a 50% stake in two holding companies holding a portfolio of wind and solar assets in France, to la Caisse des Dépôts et Consignations.
  • Crédit Agricole Home Loan SFH issues €1.25 billion Soft Bullet Green Covered BondsJones Day represented Crédit Agricole Home Loan SFH, as issuer, in connection with its inaugural green issuance of €1.25 billion (US$1.38 billion) Soft Bullet Green Covered Bonds.
  • Gilbert Dupont; Joh. Berenberg, Gossler & Co. KG; and Portzamparc complete IPO of BoostheatJones Day advised Gilbert Dupont; Joh. Berenberg, Gossler & Co. KG; and Portzamparc, as joint global coordinators, joint lead managers, and joint bookrunners, in connection with the initial public offering of Boostheat SA, a designer, developer, and producer of technologically advanced, energy efficient, and sustainable heating solutions, on the regulated market of Euronext in Paris.
  • Voltalia completes €376 million capital increase with shareholders’ preferential subscription rightsJones Day represented Voltalia S.A. in connection with its €376 million offering by way of preferential subscription rights allocated to Voltalia's existing shareholders in a public offering in France and internationally in private placements to institutional investors.
  • Garmin® acquires Tacx, the leading manufacturer of indoor bike trainersJones Day advised Garmin Ltd. in its acquisition of the Tacx group, a Dutch family business that designs and manufactures high end indoor bike trainers, tools and accessories, as well as indoor training software and applications.
  • SVB Leerink, Barclays, Bryan Garnier, and Natixis underwrite $155.4 million Nasdaq IPO by GenfitJones Day acted as French counsel to the underwriters, led by SVB Leerink and Barclays, as global coordinators, and Bryan Garnier and Natixis, as European bookrunners, in connection with the initial public offering of Genfit S.A., a French Euronext Paris-listed biotechnology company on Nasdaq for a total aggregate amount of $155.4 million, after full exercise of the over-allotment option.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
  • Creadev invests in InnovaFeedJones Day represented Creadev and Temasek in connection with their investment in InnovaFeed, a biotech company producing high quality insect meals for the feed industry.
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma PlcJones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million).
  • Speaking Engagements

    • 12 avril 2018
      Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
    • November 9, 2016
      Jones Day Global Life Sciences Conference – 2016 Issues & Trends